Science
Mechanism of Action
Functions through synchronized pathways: the 4-butylresorcinol component inhibits tyrosinase and TRP-1 enzymes to halt melanin production at the source, while the phytosphingosine component integrates into the stratum corneum to restore barrier integrity and provide antimicrobial protection that prevents post-inflammatory hyperpigmentation formation.
Research
Clinical Evidence
Medium confidence0.5%
Key findings
- 01 B16 melanoma cell studies at 0.1-1.0% showed significant melanin synthesis inhibition through dual enzyme suppression
- 02 Clinical evaluation at 0.5-2.0% demonstrated barrier function improvement alongside visible hyperpigmentation reduction
Transparency
Dusting Analysis
As a specialized hybrid molecule with documented efficacy starting at 0.1%, concentrations below this threshold would be insufficient for meaningful brightening effects
The Formula
Formulation
Stability
Enhanced stability profile compared to pure 4-butylresorcinol, often formulated in liposomal or micellar dispersions for water-based products
Synergies
- Ceramides
- Barrier lipids
- Anti-inflammatory agents
Conflicts
- Strong oxidizing agents
- Highly alkaline formulations (pH >8.0)
- Strongly acidic environments (pH <4.0)
Safety
Safety Profile
EU CosIng database listed with favorable safety profile based on well-characterized individual components
Your Skin
Skin Compatibility
Our Assessment
Verdict
A well-engineered dual-action complex that addresses both pigmentation and barrier function with solid research backing, though limited commercial availability may restrict widespread use.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources